Chiba and colleagues highlighted the ability of TIM3 to bind and sequester HMGB1 away from TLR, thus avoiding the sensing of tumour-derived nucleic acids bound to HMGB1 itself. The gene discussed is HAVCR2; the disease is neoplasm.